153 related articles for article (PubMed ID: 38162847)
1. Impact of anticancer drugs on the therapeutic efficacy and side effects of hepatic arterial embolization for hepatocellular carcinoma.
Ihira H; Sonomura T; Makitani A; Makitani K; Fukuda K; Tanaka R; Koyama T; Sato H; Wan K; Ueno M; Ida Y; Kawai N; Minamiguchi H
JGH Open; 2023 Dec; 7(12):884-888. PubMed ID: 38162847
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of transcatheter embolization/chemoembolization (TAE/TACE) for the treatment of single hepatocellular carcinoma.
Miraglia R; Pietrosi G; Maruzzelli L; Petridis I; Caruso S; Marrone G; Mamone G; Vizzini G; Luca A; Gridelli B
World J Gastroenterol; 2007 Jun; 13(21):2952-5. PubMed ID: 17589945
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of a microballoon catheter in transarterial chemoembolization of hepatocellular carcinoma using miriplatin, a lipophilic anticancer drug: Short-term results.
Ogawa M; Takayasu K; Hirayama M; Miura T; Shiozawa K; Abe M; Matsumoto N; Nakagawara H; Ohshiro S; Yamamoto T; Tanaka N; Moriyama M; Mutou H; Yamamoto Y; Irie T
Hepatol Res; 2016 Mar; 46(3):E60-9. PubMed ID: 25974615
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X
Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
[TBL] [Abstract][Full Text] [Related]
5. Usefulness and limitations of balloon-occluded transcatheter arterial chemoembolization using miriplatin for patients with four or fewer hepatocellular carcinoma nodules.
Kawamura Y; Ikeda K; Fujiyama S; Hosaka T; Kobayashi M; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Arase Y; Kumada H
Hepatol Res; 2017 Mar; 47(4):338-346. PubMed ID: 27249401
[TBL] [Abstract][Full Text] [Related]
6. Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Shirono T; Iwamoto H; Niizeki T; Shimose S; Nakano M; Satani M; Okamura S; Noda Y; Kamachi N; Kuromatsu R; Sakai M; Nomiyama M; Kuwano T; Tanaka M; Koga H; Torimura T
Oncology; 2019; 96(2):79-86. PubMed ID: 30293080
[TBL] [Abstract][Full Text] [Related]
7. Comparison of blood dynamics of anticancer drugs (cisplatin, mitomycin C, epirubicin) in treatment groups of hepatic arterial infusion, hepatic arterial infusion with lipiodol and transcatheter arterial chemoembolization with lipiodol plus gelatin sponge particles in a swine model.
Ikoma A; Kawai N; Sato M; Minamiguchi H; Nakai M; Nakata K; Tanaka T; Sonomura T
Hepatol Res; 2012 Dec; 42(12):1227-35. PubMed ID: 22607607
[TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Minamiguchi H; Nakai M; Takasaka I; Nakata K; Ikoma A; Sawa N; Sonomura T; Shirai S
Jpn J Radiol; 2010 Jun; 28(5):362-8. PubMed ID: 20585924
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
[TBL] [Abstract][Full Text] [Related]
10. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
11. Balloon-Occluded Trans-Arterial Chemoembolization Technique with Alternate Infusion of Cisplatin and Gelatin Slurry for Small Hepatocellular Carcinoma Nodules Adjacent to the Glisson Sheath.
Irie T; Takahashi N; Kamoshida T
Biomed Res Int; 2019; 2019():8350926. PubMed ID: 31211142
[TBL] [Abstract][Full Text] [Related]
12. Balloon-Occluded Trans-Arterial Chemo-Embolization Technique with Repeated Alternate Infusion of Cisplatin Solution and Sparse Gelatin Slurry (RAIB-TACE) for Large Hepatocellular Carcinoma Nodules More than 7 cm in Diameter.
Irie T; Takahashi N; Kamoshida T; Kashimura J; Ariga H
Biomed Res Int; 2020; 2020():9289321. PubMed ID: 32051830
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of combined bland embolization and chemoembolization for huge (≥10 cm) hepatocellular carcinoma.
Hidaka T; Anai H; Sakaguchi H; Sueyoshi S; Tanaka T; Yamamoto K; Morimoto K; Nishiofuku H; Maeda S; Nagata T; Kichikawa K
Minim Invasive Ther Allied Technol; 2021 Aug; 30(4):221-228. PubMed ID: 32031474
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Sahara S; Kawai N; Sato M; Tanaka T; Ikoma A; Nakata K; Sanda H; Minamiguchi H; Nakai M; Shirai S; Sonomura T
Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1363-71. PubMed ID: 22358993
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma.
Arai H; Abe T; Takayama H; Toyoda M; Ueno T; Kakizaki S; Sato K
Hepatol Res; 2015 Jun; 45(6):663-6. PubMed ID: 25132539
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma.
Ono Y; Yoshimasu T; Ashikaga R; Inoue M; Shindou H; Fuji K; Araki Y; Nishimura Y
Am J Clin Oncol; 2000 Dec; 23(6):564-8. PubMed ID: 11202797
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
18. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of arterial embolization with warmed miriplatin for multiple hepatocellular carcinoma.
Ikeda K; Kawamura Y; Kobayashi M; Fujiyama S; Sezaki H; Hosaka T; Akuta N; Saitoh S; Suzuki F; Suzuki Y; Arase Y; Kumada H
Hepatol Res; 2017 Jun; 47(7):632-640. PubMed ID: 27487085
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
Liu C; Sun L; Xu J; Zhao Y
World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
